Tiny brain probe to track drug levels in deadly tumors
NCT ID NCT05413304
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study aims to see if researchers can measure how much of the cancer drug abemaciclib reaches brain tumors in people with aggressive gliomas. Participants take the drug for a few days, then undergo surgery to place a tiny tube in the brain that collects fluid samples for 48 hours. The study includes up to 1 person aged 18-39 with recurrent high-grade or diffuse midline glioma.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.